secwatch.observer — SEC 8-K summary
======================================

Issuer:     Profound Medical Corp. (PROF)
CIK:        0001628808
Form:       8-K
Filed at:   2026-03-09T23:59:59+00:00
Accession:  0001171843-26-001406
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Profound Medical to present first CAPTAIN trial outcomes at EAU 2026, host investor call March 13
--------------------------------------------------------------------------------

- First CAPTAIN trial outcomes (TULSA vs radical prostatectomy) presented at EAU 2026 on March 13 at 9:40 a.m. EDT.
- Investor webinar at 11:30 a.m. EDT on March 13 with Dr. Laurence Klotz reviewing data and commercial implications.
- Management to participate in Roth Conference March 22-24 in Dana Point, CA; one-on-one meetings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628808/000117184326001406/0001171843-26-001406-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628808/000117184326001406/f8k_030926.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-001406

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer